These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38558097)

  • 1. Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation.
    Liuzzo G; Pedicino D
    Eur Heart J; 2024 May; 45(19):1699-1700. PubMed ID: 38558097
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
    Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
    J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for conversion of atrial fibrillation.
    Dell'Orfano JT; Luck JC; Wolbrette DL; Patel H; Naccarelli GV
    Am Fam Physician; 1998 Aug; 58(2):471-80. PubMed ID: 9713400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic cardioversion for atrial fibrillation and flutter.
    Cayley WE
    Am Fam Physician; 2005 Dec; 72(11):2217-9. PubMed ID: 16342843
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department: A Systematic Review and Network Meta-analysis.
    deSouza IS; Tadrous M; Sexton T; Benabbas R; Carmelli G; Sinert R
    Ann Emerg Med; 2020 Jul; 76(1):14-30. PubMed ID: 32173135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
    Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
    Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical or pharmacologic cardioversion for atrial fibrillation in the ED?
    MacKenzie M; Stewart D; Hall C
    CJEM; 2021 Jan; 23(1):32-33. PubMed ID: 33683610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels.
    Simó-Vicens R; Sauter DRP; Grunnet M; Diness JG; Bentzen BH
    Eur J Pharmacol; 2017 May; 803():118-123. PubMed ID: 28322838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological restoration and maintenance of sinus rhythm by antiarrhythmic agents].
    Sugi K
    J Cardiol; 1999 Mar; 33 Suppl 1():59-64. PubMed ID: 10342138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prevention of atrial fibrillation with non-antiarrhythmic pharmacologic therapy.
    Lozano HF; Conde CA; Florin T; Lamas GA
    Heart Rhythm; 2005 Sep; 2(9):1000-7. PubMed ID: 16171759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter.
    Rogers KC; Wolfe DA
    J Emerg Med; 2001 Jan; 20(1):67-71. PubMed ID: 11165840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation.
    Pluymaekers NAHA; Dudink EAMP; Luermans JGLM; Meeder JG; Lenderink T; Widdershoven J; Bucx JJJ; Rienstra M; Kamp O; Van Opstal JM; Alings M; Oomen A; Kirchhof CJ; Van Dijk VF; Ramanna H; Liem A; Dekker LR; Essers BAB; Tijssen JGP; Van Gelder IC; Crijns HJGM;
    N Engl J Med; 2019 Apr; 380(16):1499-1508. PubMed ID: 30883054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic control of heart rate in atrial fibrillation.
    Falk RH
    Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardioversion of atrial fibrillation].
    Jóanesarson J; Riahi S; Hjortshøj S
    Ugeskr Laeger; 2013 Oct; 175(43):2549-53. PubMed ID: 24629150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
    Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
    Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kv1.5 Inhibitors for Treatment of Atrial Fibrillation: A Tradeoff between Selectivity and Non-selectivity.
    Guo X; Chen W; Sun H; You Q
    Curr Top Med Chem; 2016; 16(16):1843-54. PubMed ID: 26975505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.